Serum Proteomic Profiles Suggest Celecoxib-Modulated Targets and Response Predictors

Cancer Research

Volumn 64, Issue 8, 2004, Pages 2904-2909

  Xiao, Zhen ^a   Luke, Brian T ^a   Izmirlian, Grant ^b   Umar, Asad ^b   Lynch, Patrick M ^c   Phillips, Robin K S ^d   Patterson, Sherri ^c   Conrads, Thomas P ^a   Veenstra, Timothy D ^a   Greenwald, Peter ^b   Hawk, Ernest T ^b   Ali, Iqbal U ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; TUMOR MARKER;

ADENOMATOUS POLYP; ALGORITHM; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER PREVENTION; CANCER THERAPY; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TARGETING; GENE EXPRESSION; HUMAN; MEDICAL DECISION MAKING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ADENOMATOUS POLYPOSIS COLI; ANTICARCINOGENIC AGENTS; BLOOD PROTEINS; CLINICAL TRIALS, PHASE II; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SPECTROMETRY; PROTEOME; PYRAZOLES; RANDOMIZED CONTROLLED TRIALS; SULFONAMIDES;

EID: 5444266793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3754     Document Type: Article

References (30)

1. Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000;18:1967-79.
2. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
3. Hao X, Bishop AE, Wallace M, et al. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 1999;187:295-301.
4. Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000;1470:M69-78.
5. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003;24:96-102.
6. Jacoby RF, Cole CE, Tutsch K, et al. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res 2000;60:1864-70.
7. Giardiello FM, Yang VW, Hylind LM. et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002;346:1054-9.
8. Mahmoud NN, Dannenberg AJ, Mestre J, et al. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery 1998;124:225-31.
9. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
10. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90.
11. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003;125:328-36.
12. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87: 803-9.
13. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 2000;60:5040-4.
14. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
15. Yip TT, Lomas L. SELDI ProteinChip array in oncoproteomic research. Technol Cancer Res Treat 2002;1:273-80.
16. von Eggeling F, Junker K, Fiedle W, et al. Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis 2001;22:2898-902.
17. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-77.
18. Adam BL, Qu Y. Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
19. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
20. Petricoin EF, 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst (Bethesda) 2002;94:1576-8.
21. Poon TC, Yip TT, Chan AT, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-60.
22. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267-79.
23. Lindstrom MJ, Bates DM. Algorithms for linear mixed-effects models for repeated-measures data. J Am Stat Assoc 1988;83:1014-22.
24. Breiman L. Random forests. Mach Learn 2001;45:5-32,.
25. Breiman L. Manual on setting up, using, and understanding random forests, V3.1 edition. 2002. Available from: http://oz.berkeley.edu/users/breiman/Using_random_forests_V3.1.pdf or ftp://ftp.stat.berkeley.edu/pub/users/breiman/Using_random_forests_V3.1.pdf.
26. Liaw A, Weiner M. The random forest package in R. 2003. Available from: http://www.r-project.org.
27. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids 1996;54:83-94.
28. Moore BC, Simmons DL. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Curr Med Chem 2000;7:1131-44.
29. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19-27.
30. Tsujii M, Kawano S, Tsuji S. Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.